Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021Xiaodong Zhou, Tamer N. Abdelbaki, Anoop Misra et al.|EClinicalMedicine|2024Cited by 188
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensusXufen Zeng, Xin Liu, Krista A Varady et al.|Metabolism|2024Cited by 111
Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15–39, 1990–2021Xiaodong Zhou, Mohit Kehar, Qin‐Fen Chen et al.|Clinical Nutrition|2024Cited by 44
Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021Xiaodong Zhou, Tamer N. Abdelbaki, Qin‐Fen Chen et al.|EClinicalMedicine|2024Cited by 16
Redefinition of Fatty Liver Disease from NAFLD to MAFLD through the Lens of Drug Development and Regulatory ScienceYasser Fouad, Puneet S. Arora, Melissa Palmer et al.|Figshare|2022Cited by 14